Insulet
PODD
#1185
Rank
HK$152.64 B
Marketcap
HK$2,168
Share price
-0.14%
Change (1 day)
3.94%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: HK$152.64 Billion

As of January 2026 Insulet has a market cap of HK$152.64 Billion. This makes Insulet the world's 1185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$152.64 B-3.44%
2025HK$158.08 B9.49%
2024HK$144.37 B22.01%
2023HK$118.33 B-25.92%
2022HK$159.74 B11.64%
2021HK$143.08 B9.52%
2020HK$130.64 B56.32%
2019HK$83.57 B127.34%
2018HK$36.76 B17.2%
2017HK$31.36 B86.95%
2016HK$16.77 B0.53%
2015HK$16.69 B-17.02%
2014HK$20.11 B27.42%
2013HK$15.78 B98.46%
2012HK$7.95 B14.76%
2011HK$6.93 B26.46%
2010HK$5.48 B31.12%
2009HK$4.18 B173.37%
2008HK$1.52 B-67.41%
2007HK$4.69 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Insulet was reported to be:

HK$152.54 Billion
by Nasdaq info icon info icon
HK$152.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ICU Medical
ICUI
HK$28.53 B-81.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
HK$11.04 B-92.76%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$214.75 B 40.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$4.012 T 2,528.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.686 T 1,004.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$964.06 B 531.58%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$7.527 T 4,831.56%๐Ÿ‡บ๐Ÿ‡ธ USA